Evidence map›Paper›PMID 40612346›Full record

ArticleFrontiers in oncology2025

DynTransNet: Dynamic Transformer Network with multi-scale attention for liver cancer segmentation.

Siming Zheng, A S M Sharifuzzaman Sagar, Yu Chen, Zehao Yu, Shi Ying, Yongyi Zeng

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Siming ZhengThe First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
A S M Sharifuzzaman SagarDepartment of Artificial and Robotics, Sejong University, Seoul, Republic of Korea.
Yu ChenAI Lab, MetaSyntec Co., LTD, George Town, Cayman Islands.
Zehao YuDepartment of Hepatopancreatobiliary Surgery, First Hospital of Ningbo University, Ningbo, China.
Shi YingDepartment of Engineering Technology, Ningbo Wedge Medical Technology Co., LTD, Ningbo, China.
Yongyi ZengThe First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hepatocellular carcinoma (HCC), a predominant subtype of liver cancer, remains Q7 a major contributor to global cancer mortality. Accurate delineation of liver tumors in CT and MRI scans is critical for treatment planning and clinical decision-making. However, manual segmentation is time-consuming, errorprone, and inconsistent, necessitating reliable automated approaches. Methods: This study presents a novel U-shaped segmentation framework inspired by U-Net, designed to enhance accuracy and robustness. The encoder incorporates Dynamic Multi-Head Self-Attention (D-MSA) to capture both global and local spatial dependencies, while the decoder uses skip connections to preserve spatial detail. Additionally, a Feature Mix Module (FM-M) blends multiscale features, and a Residual Module (RM) refines feature representations and stabilizes training. The proposed framework addresses key challenges such as boundary precision, complex structural relationships, and dataset imbalance. Results: Experimental results demonstrate superior segmentation performance, achieving a mean Dice score of 86.12 on the ATLAS dataset and 93.12 on the LiTS dataset. Discussion: The proposed method offers a robust, efficient tool for liver tumor segmentation and holds strong potential to streamline diagnostic workflows and improve automated medical image analysis in clinical practice.

Indexed as

deep learninghepatocellular carcinomaliver cancerliver tumorsegmentation

Identifiers

PMID40612346
PMCPMC12221907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.